13F Data
13F filer · CIK 1977548

Checkpoint Capital L.P.

SAN FRANCISCO, CA · filing since Q4 2023 · last filing Aug 14, 2026
Reported value
$389.8M
+$111.1M vs prior
Positions
6
New / sold out
0 / 2
Added / reduced
3 / 3
Turnover
9.6%
buys $53.3M · sells $32.0M
Top-10 weight
100.0%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
AddedREVOLUTION MEDICINES INC+147,814+56.3%+$27.7M
AddedCYTOKINETICS INC+295,000+163.9%+$25.1M
AddedTREVI THERAPEUTICS INC+25,000+50.0%+$466.2K

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
ReducedARGENX SE-21,717-14.2%$-20.1M
ReducedRHYTHM PHARMACEUTICALS INC-41,200-3.4%$-4.6M
ReducedDISC MEDICINE INC-46,536-16.2%$-3.4M
Sold outSEPTERNA INC-100,300-100.0%$-2.4M
Sold outCRINETICS PHARMACEUTICALS IN-40,230-100.0%$-1.5M

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2023: $165.1MQ1 2024: $149.6MQ2 2024: $165.9MQ3 2024: $201.6MQ4 2024: $196.5MQ1 2025: $182.3MQ2 2025: $214.6MQ3 2025: $298.5MQ4 2025: $320.1MQ1 2026: $278.7MQ2 2026: $389.8M
Q4 2023Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1RHYTHM PHARMACEUTICALS INCCOM1,186,000$131.7M33.79%
2ARGENX SESPONSORED ADR131,283$121.8M31.25%
3REVOLUTION MEDICINES INCCOM410,353$76.9M19.72%
4CYTOKINETICS INCCOM NEW475,000$40.5M10.38%
5DISC MEDICINE INCCOM240,125$17.6M4.51%
6TREVI THERAPEUTICS INCCOM75,000$1.4M0.36%